Investing.com - Asensus Surgical (NYSE: ASXC) reported second quarter EPS of $-0.090, worse than the analyst estimate of $-0.080. Revenue for the quarter came in at $1.08M versus the consensus estimate of $1.07M.
Asensus Surgical's stock price closed at $0.330. It is down -45.920% in the last 3 months and down -51.640% in the last 12 months.
Asensus Surgical saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Asensus Surgical's stock price’s past reactions to earnings here.
According to InvestingPro, Asensus Surgical's Financial Health score is "fair performance".
Check out Asensus Surgical's recent earnings performance, and Asensus Surgical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar